HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by Silvercrest Asset Management Group LLC

Silvercrest Asset Management Group LLC trimmed its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 2.3% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,868 shares of the company’s stock after selling 43 shares during the quarter. Silvercrest Asset Management Group LLC’s holdings in HCA Healthcare were worth $623,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the company. Parkside Financial Bank & Trust increased its stake in HCA Healthcare by 8.2% in the 4th quarter. Parkside Financial Bank & Trust now owns 461 shares of the company’s stock valued at $125,000 after buying an additional 35 shares during the period. FinTrust Capital Advisors LLC boosted its position in shares of HCA Healthcare by 26.7% during the 4th quarter. FinTrust Capital Advisors LLC now owns 166 shares of the company’s stock worth $45,000 after purchasing an additional 35 shares in the last quarter. Financial Counselors Inc. boosted its position in shares of HCA Healthcare by 1.4% during the 1st quarter. Financial Counselors Inc. now owns 2,642 shares of the company’s stock worth $881,000 after purchasing an additional 36 shares in the last quarter. Ballentine Partners LLC boosted its position in shares of HCA Healthcare by 1.0% during the 1st quarter. Ballentine Partners LLC now owns 3,879 shares of the company’s stock worth $1,294,000 after purchasing an additional 38 shares in the last quarter. Finally, Valley Wealth Managers Inc. boosted its position in shares of HCA Healthcare by 4.1% during the 4th quarter. Valley Wealth Managers Inc. now owns 981 shares of the company’s stock worth $266,000 after purchasing an additional 39 shares in the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Stock Up 0.5 %

HCA stock opened at $363.05 on Thursday. The company has a market capitalization of $93.69 billion, a P/E ratio of 18.10, a PEG ratio of 1.38 and a beta of 1.68. The firm has a 50 day simple moving average of $332.49 and a 200-day simple moving average of $324.10. The company has a current ratio of 1.06, a quick ratio of 0.94 and a debt-to-equity ratio of 27.11. HCA Healthcare, Inc. has a twelve month low of $215.96 and a twelve month high of $366.10.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, topping analysts’ consensus estimates of $4.97 by $0.53. The firm had revenue of $17.49 billion during the quarter, compared to the consensus estimate of $17.05 billion. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The firm’s revenue was up 10.3% on a year-over-year basis. During the same quarter in the previous year, the company posted $4.29 earnings per share. On average, equities research analysts predict that HCA Healthcare, Inc. will post 22.43 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, September 30th. Stockholders of record on Monday, September 16th will be issued a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a dividend yield of 0.73%. The ex-dividend date of this dividend is Monday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is 13.16%.

Insider Activity

In related news, EVP Michael S. Cuffe sold 1,600 shares of HCA Healthcare stock in a transaction dated Monday, May 6th. The shares were sold at an average price of $309.00, for a total transaction of $494,400.00. Following the sale, the executive vice president now directly owns 34,124 shares in the company, valued at $10,544,316. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In other HCA Healthcare news, SVP Christopher F. Wyatt sold 4,000 shares of the business’s stock in a transaction dated Monday, July 29th. The shares were sold at an average price of $360.20, for a total value of $1,440,800.00. Following the sale, the senior vice president now directly owns 40,449 shares in the company, valued at $14,569,729.80. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Michael S. Cuffe sold 1,600 shares of the business’s stock in a transaction dated Monday, May 6th. The stock was sold at an average price of $309.00, for a total transaction of $494,400.00. Following the completion of the sale, the executive vice president now owns 34,124 shares in the company, valued at $10,544,316. The disclosure for this sale can be found here. Over the last quarter, insiders sold 20,268 shares of company stock valued at $6,804,285. 1.60% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

HCA has been the topic of several recent research reports. SVB Leerink boosted their price objective on shares of HCA Healthcare from $367.00 to $396.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 24th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $335.00 price objective on shares of HCA Healthcare in a research report on Wednesday, July 24th. StockNews.com upgraded shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Monday, July 1st. Wells Fargo & Company upped their target price on shares of HCA Healthcare from $315.00 to $365.00 and gave the company an “equal weight” rating in a report on Tuesday. Finally, Royal Bank of Canada upped their target price on shares of HCA Healthcare from $329.00 to $378.00 and gave the company an “outperform” rating in a report on Wednesday, July 24th. Four investment analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $344.06.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.